The unidentified ailment has sickened 1,300 people and led to more than 50 deaths. Regardless of the cause, experts say ...

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers ...

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers ...

The malaria parasite is still killing almost half a million people every year. A project has now identified a gene that holds ...

BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...

Malaria drug pyronaridine shows promise for treating cancer according to research led by UTEP's Renato Aguilera.

comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite that causes malaria in humans, has been generated. The map contains the most ...

Compounding this challenge, malarial parasites have become resistant to nearly every available antimalarial treatment. While a class of drugs known as artemisinin-based combination therapies (ACT) has ...

Aguilera realized that the molecular structure of pyronaridine could be useful in fighting cancer cells. EL PASO, Texas (March 3, 2025) – Can a drug that’s used to treat malaria be repurposed ...